Researchers with McMaster University and Denmark-based pharmaceutical company ALK-Abello A/S have made a groundbreaking discovery: a new cell that remembers allergies.
Feb 7, 2024
0
216
Spring welcomes warm weather and sun, but it also is the height of allergy season. Dr. Sanjiv Sur, an allergist at Baylor College of Medicine, explains the importance of managing seasonal allergy symptoms and the best methods ...
Mar 26, 2019
0
39
(HealthDay)—Administration of allergen immunotherapy (AIT) in patients with allergic asthma leads to lower short-term symptom and medication scores, according to a review published online May 19 in Allergy.
Jun 4, 2017
0
62
Although sublingual immunotherapy (SLIT) has become an effective treatment option for many allergies, about 20–30% of patients don't respond to SLIT for Japanese cedar pollinosis—a highly common disease. In a recent study, ...
Mar 7, 2022
0
4
People allergic to peanuts may have a new way to protect themselves from severe allergic reactions to accidental peanut exposure. It's called sublingual immunotherapy—or SLIT—and it involves putting a miniscule amount ...
Sep 4, 2019
0
7
A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children.
Feb 28, 2023
0
28
(HealthDay)—Allergen immunotherapy (AIT) may be cost-effective for allergic rhinitis, and for venom allergy in high-risk subgroups, according to research published online July 18 in Allergy.
Jul 31, 2017
0
10
Regular dietary peanut consumption after completing oral immunotherapy (OIT) or sublingual immunotherapy (SLIT) for peanut allergy may provide continued protection against accidental exposures to the allergen, according to ...
Feb 24, 2019
0
2
Allergy shots (subcutaneous immunotherapy or SCIT) have been available for more than 100 years. Allergy tablets (sublingual immunotherapy or SLIT) have been approved by the Food and Drug Administration (FDA) for use in the ...
Apr 2, 2019
0
6
(HealthDay)—For patients with allergic rhinitis (AR), house dust mite (HDM) sublingual immunotherapy is effective and seems safe, according to a study published online July 29 in Allergy.
Aug 3, 2016
0
36
